Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Neumann

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Vaccines|December 28, 2021
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in AdultsJoseph Eiden, Gilad Gordon, Carlos Fierro, et al.
BMC Systems Biology|October 4, 2013
A comprehensive map of the influenza A virus replication cycleYukiko Matsuoka, Hiromi Matsumae, Manami Katoh, et al.
Vaccine|September 6, 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamstersIrene Hoxie, Kirill Vasilev, Jordan J Clark, et al.
Journal of Virology|July 15, 2005
Characterization of a human H5N1 influenza A virus isolated in 2003Kyoko Shinya, Masato Hatta, Shinya Yamada, et al.
Journal of Virology|December 6, 2019
Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and FerretsGongxun Zhong, Shufang Fan, Masato Hatta, et al.
The Journal of Infectious Diseases|November 9, 2022
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in AdultsJoseph Eiden, Carlos Fierro, Howard Schwartz, et al.
Plos Pathogens|January 7, 2021
Novel modulators of p53-signaling encoded by unknown genes of emerging virusesDina Alzhanova, Kathleen Corcoran, Aubrey G Bailey, et al.
Virus Evolution|February 23, 2023
Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammalsKatarina M Braun, Luis A Haddock Iii, Chelsea M Crooks, et al.
The Lancet. Infectious Diseases|July 14, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trialJoseph Eiden, Carlos Fierro, Alexander White, et al.
Viruses|May 27, 2023
Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird MarketsLizheng Guan, Gongxun Zhong, Shufang Fan, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Vaccines|December 28, 2021
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in AdultsJoseph Eiden, Gilad Gordon, Carlos Fierro, et al.
BMC Systems Biology|October 4, 2013
A comprehensive map of the influenza A virus replication cycleYukiko Matsuoka, Hiromi Matsumae, Manami Katoh, et al.
Vaccine|September 6, 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamstersIrene Hoxie, Kirill Vasilev, Jordan J Clark, et al.
Journal of Virology|July 15, 2005
Characterization of a human H5N1 influenza A virus isolated in 2003Kyoko Shinya, Masato Hatta, Shinya Yamada, et al.
Journal of Virology|December 6, 2019
Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and FerretsGongxun Zhong, Shufang Fan, Masato Hatta, et al.
The Journal of Infectious Diseases|November 9, 2022
Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in AdultsJoseph Eiden, Carlos Fierro, Howard Schwartz, et al.
Plos Pathogens|January 7, 2021
Novel modulators of p53-signaling encoded by unknown genes of emerging virusesDina Alzhanova, Kathleen Corcoran, Aubrey G Bailey, et al.
Virus Evolution|February 23, 2023
Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammalsKatarina M Braun, Luis A Haddock Iii, Chelsea M Crooks, et al.
The Lancet. Infectious Diseases|July 14, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trialJoseph Eiden, Carlos Fierro, Alexander White, et al.
Viruses|May 27, 2023
Highly Pathogenic H5 Influenza Viruses Isolated between 2016 and 2017 in Vietnamese Live Bird MarketsLizheng Guan, Gongxun Zhong, Shufang Fan, et al.
Pageof 19